Literature DB >> 24362016

Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity.

Hilary Afeseh Ngwa1, Arthi Kanthasamy1, Huajun Jin1, Vellareddy Anantharam1, Anumantha G Kanthasamy2.   

Abstract

Epidemiological evidence indicates chronic environmental exposure to transition metals may play a role in chronic neurodegenerative conditions such as Parkinson's disease (PD). Chronic inhalation exposure to welding fumes containing metal mixtures may be associated with development of PD. A significant amount of vanadium is present in welding fumes, as vanadium pentoxide (V2O5), and incorporation of vanadium in the production of high strength steel has become more common. Despite the increased vanadium use in recent years, the neurotoxicological effects of this metal are not well characterized. Recently, we demonstrated that V2O5 induces dopaminergic neurotoxicity via protein kinase C delta (PKCδ)-dependent oxidative signaling mechanisms in dopaminergic neuronal cells. Since anosmia (inability to perceive odors) and non-motor deficits are considered to be early symptoms of neurological diseases, in the present study, we examined the effect of V2O5 on the olfactory bulb in animal models. To mimic the inhalation exposure, we intranasally administered C57 black mice a low-dose of 182μg of V2O5 three times a week for one month, and behavioral, neurochemical and biochemical studies were performed. Our results revealed a significant decrease in olfactory bulb weights, tyrosine hydroxylase (TH) levels, levels of dopamine (DA) and its metabolite, 3,4-dihydroxyphenylacetic acid (DOPAC) and increases in astroglia of the glomerular layer of the olfactory bulb in the treatment groups relative to vehicle controls. Neurochemical changes were accompanied by impaired olfaction and locomotion. These findings suggest that nasal exposure to V2O5 adversely affects olfactory bulbs, resulting in neurobehavioral and neurochemical impairments. These results expand our understanding of vanadium neurotoxicity in environmentally-linked neurological conditions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neurotoxicity; Non-motor symptoms; Olfactory system; Parkinson's disease; Risk assessment; Vanadium

Mesh:

Substances:

Year:  2013        PMID: 24362016      PMCID: PMC4062607          DOI: 10.1016/j.neuro.2013.12.004

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  86 in total

1.  Olfactory function and olfactory bulb volume in patients with postinfectious olfactory loss.

Authors:  Philippe Rombaux; André Mouraux; Bernard Bertrand; Georges Nicolas; Thierry Duprez; Thomas Hummel
Journal:  Laryngoscope       Date:  2006-03       Impact factor: 3.325

Review 2.  Manganese and its role in Parkinson's disease: from transport to neuropathology.

Authors:  Michael Aschner; Keith M Erikson; Elena Herrero Hernández; Elena Herrero Hernández; Ronald Tjalkens
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

3.  A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models.

Authors:  Anumantha G Kanthasamy; Vellareddy Anantharam; Danhui Zhang; Calivarathan Latchoumycandane; Huajun Jin; Siddharth Kaul; Arthi Kanthasamy
Journal:  Free Radic Biol Med       Date:  2006-08-25       Impact factor: 7.376

4.  Environmental risk factors and Parkinson's disease: a case-control study in Taiwan.

Authors:  H H Liou; M C Tsai; C J Chen; J S Jeng; Y C Chang; S Y Chen; R C Chen
Journal:  Neurology       Date:  1997-06       Impact factor: 9.910

Review 5.  Manganese neurotoxicity: a mechanistic hypothesis.

Authors:  M A Verity
Journal:  Neurotoxicology       Date:  1999 Apr-Jun       Impact factor: 4.294

6.  Environmental risk factors for Parkinson's disease in an urban multiethnic community.

Authors:  K Marder; G Logroscino; B Alfaro; H Mejia; A Halim; E Louis; L Cote; R Mayeux
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

7.  Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration.

Authors:  R L Doty; J M Risser
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature.

Authors:  S Nagatomo; F Umehara; K Hanada; Y Nobuhara; S Takenaga; K Arimura; M Osame
Journal:  J Neurol Sci       Date:  1999-01-01       Impact factor: 3.181

Review 9.  Manganese neurotoxicity.

Authors:  Allison W Dobson; Keith M Erikson; Michael Aschner
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

Review 10.  Manganism and idiopathic parkinsonism: similarities and differences.

Authors:  D B Calne; N S Chu; C C Huang; C S Lu; W Olanow
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

View more
  14 in total

1.  Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.

Authors:  Monica R Langley; Shivani Ghaisas; Muhammet Ay; Jie Luo; Bharathi N Palanisamy; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2017-06-20       Impact factor: 4.294

2.  Neuroprotective effect of carnosine in the olfactory bulb after vanadium inhalation in a mouse model.

Authors:  Laura Colín-Barenque; Patricia Bizarro-Nevares; Adriana González Villalva; Jose Pedraza-Chaverri; Omar Noel Medina-Campos; Ruben Jimenez-Martínez; Daniela S Rodríguez-Rangel; Stefanie Reséndiz; Teresa I Fortoul
Journal:  Int J Exp Pathol       Date:  2018-09-09       Impact factor: 1.925

3.  Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes.

Authors:  Souvarish Sarkar; Emir Malovic; Dilshan S Harischandra; Hilary A Ngwa; Anamitra Ghosh; Colleen Hogan; Dharmin Rokad; Gary Zenitsky; Huajun Jin; Vellareddy Anantharam; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  Neurotoxicology       Date:  2017-05-21       Impact factor: 4.294

4.  Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease.

Authors:  Qi Xu; Monica Langley; Anumantha G Kanthasamy; Manju B Reddy
Journal:  J Nutr       Date:  2017-08-23       Impact factor: 4.798

5.  Respirable Uranyl-Vanadate-Containing Particulate Matter Derived From a Legacy Uranium Mine Site Exhibits Potentiated Cardiopulmonary Toxicity.

Authors:  Katherine E Zychowski; Vamsi Kodali; Molly Harmon; Christina R Tyler; Bethany Sanchez; Yoselin Ordonez Suarez; Guy Herbert; Abigail Wheeler; Sumant Avasarala; José M Cerrato; Nitesh K Kunda; Pavan Muttil; Chris Shuey; Adrian Brearley; Abdul-Mehdi Ali; Yan Lin; Mohammad Shoeb; Aaron Erdely; Matthew J Campen
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

6.  Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.

Authors:  Anamitra Ghosh; Monica R Langley; Dilshan S Harischandra; Matthew L Neal; Huajun Jin; Vellareddy Anantharam; Joy Joseph; Timothy Brenza; Balaji Narasimhan; Arthi Kanthasamy; Balaraman Kalyanaraman; Anumantha G Kanthasamy
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-02       Impact factor: 4.147

Review 7.  Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses.

Authors:  Honglei Chen; Keran Wang; Filip Scheperjans; Bryan Killinger
Journal:  Neurobiol Dis       Date:  2021-12-23       Impact factor: 7.046

8.  Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration.

Authors:  Richard Gordon; Matthew L Neal; Jie Luo; Monica R Langley; Dilshan S Harischandra; Nikhil Panicker; Adhithiya Charli; Huajun Jin; Vellareddy Anantharam; Trent M Woodruff; Qun-Yong Zhou; Anumantha G Kanthasamy; Arthi Kanthasamy
Journal:  Nat Commun       Date:  2016-10-05       Impact factor: 14.919

9.  Nervonic acid amends motor disorder in a mouse model of Parkinson's disease.

Authors:  Dandong Hu; Yujuan Cui; Ji Zhang
Journal:  Transl Neurosci       Date:  2021-05-25       Impact factor: 1.757

10.  Vanadium toxicity in the thymic development.

Authors:  Wei Cui; Hongrui Guo; Hengmin Cui
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.